Medicine pack check sheet

Source-linked reading points

• Check REPATHA, evolocumab, subcutaneous injection, the exact device, 140 mg/mL, the actual pack and target market together. This figure is a labelled concentration/identity cue, not a web rule that can calculate anyone's injection amount, frequency or schedule, and it cannot self-convert tablets, another injection product or another-market pack.
• The current U.S. label lists a prefilled single-dose pen, SureClick® autoinjector and prefilled single-dose syringe; some needle covers contain a natural-rubber derivative, so the label flags exact-presentation review for people sensitive to latex. Similar pack names, a shared generic name or similar photos do not establish device, materials or use.
• The label includes safety information on serious hypersensitivity, including angioedema, and injection-site reactions. With breathing difficulty, swelling of the face, lips or throat, fainting or another acute serious concern, prioritise local emergency care; a webpage cannot replace assessment of such symptoms and does not direct self-stopping, make-up use or switching.
• If atorvastatin, rosuvastatin, ezetimibe, another lipid-lowering injection, anticoagulants, OTC products, herbs or supplements are also on the list, have a pharmacist or prescribing team review every actual pack and the full medicine list. A shared “lipid-lowering” goal does not make products self-combinable, alternatable, milligram-convertible or substitutable.